Jacob V.P. Eswarakumar
Krouzon Pharmaceuticals, Inc
Affiliations
Yale University
Technologies
Therapeutic
Indication
Developmental Disorders
Orphan Diseases
Executive Summary
View/DownloadKrouzon Pharmaceuticals, Inc. is developing a first-in-class treatment for ultra-rare orphan pediatric skeletal disorders.
ABCT is a Program of
An initiative of
